BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 10379470)

  • 21. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
    Miller K
    Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE; Murav'ev IuV; Nasonova VA
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M; Bianchi Porro G
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
    Nogi K; Taniguchi H; Onoda Y
    Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current state of treatment and prevention of gastroduodenal side effects of non-steroidal antirheumatic drugs].
    Bolten W
    Leber Magen Darm; 1991 Sep; 21(5):193-4, 196. PubMed ID: 1758234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misoprostol: a prostaglandin E1 analogue.
    Garris RE; Kirkwood CF
    Clin Pharm; 1989 Sep; 8(9):627-44. PubMed ID: 2507215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanical ventilation-associated pneumonia and the prevention of stress ulcer. A randomized clinical trial of antacids and ranitidine versus sucralfate].
    Sirvent JM; Verdaguer R; Ferrer MJ; Avila FJ; Díaz-Prieto A; Carratalá J
    Med Clin (Barc); 1994 Mar; 102(11):407-11. PubMed ID: 8182996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term treatment with sucralfate or cimetidine in gastric ulcer: preliminary results of a controlled randomized trial.
    Martin F; Farley A; Gagnon M; Poitras P; Bensemana D
    Scand J Gastroenterol Suppl; 1983; 83():37-41. PubMed ID: 6356319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
    Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
    Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of erosive gastropathy caused by nonsteroidal anti-inflammatory agents using low doses of antacids].
    Rybár I; Rovenský J; Orlovská M
    Vnitr Lek; 2000 Oct; 46(10):673-6. PubMed ID: 11344624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.